Method:
We describe the incompletely penetrant and variably expressed clinical
phenotype of a patient of Caribbean descent with CTLA-4 HI, and his 4
related family members (Family pedigree, clinical presentation and
genetic defect as depicted in Figure 1A-C). The study was approved by
the institutional IRB. The informed consents were obtained as per the
IRB guidelines.